Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors.
Clinical & translational immunology
View this publicationClinical & translational immunology
View this publicationOncoimmunology
View this publicationSignal transduction and targeted therapy
View this publicationBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
View this publicationJournal of the American Academy of Dermatology
View this publicationJournal of neuro-oncology
View this publicationJAMA oncology
View this publicationEuropean urology
View this publicationStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
View this publicationCancer research
View this publication